Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.980,01
-0,15%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ProMIS Neurosciences Inc (PMN) ProMIS Neurosciences Inc (PMN) Notizie

PMN

ProMIS Neurosciences (PMN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PMN
DataOraFonteTitoloSimboloCompagnia
14/05/202422:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMNProMIS Neurosciences Inc
14/05/202422:01GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
30/04/202413:00GlobeNewswire Inc.ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed AntibodiesNASDAQ:PMNProMIS Neurosciences Inc
09/04/202413:00GlobeNewswire Inc.ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
04/04/202413:00GlobeNewswire Inc.ProMIS Neurosciences to Present in Upcoming Investor Conferences in April NASDAQ:PMNProMIS Neurosciences Inc
01/04/202422:15GlobeNewswire Inc.ProMIS Neurosciences Announces Full Year 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
11/03/202412:00GlobeNewswire Inc.ProMIS Neurosciences Strengthens Global Intellectual Property PortfolioNASDAQ:PMNProMIS Neurosciences Inc
22/02/202413:00GlobeNewswire Inc.ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PMNProMIS Neurosciences Inc
22/01/202413:00GlobeNewswire Inc.ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein VaccineNASDAQ:PMNProMIS Neurosciences Inc
08/01/202413:00GlobeNewswire Inc.ProMIS Neurosciences Issues Letter to ShareholdersNASDAQ:PMNProMIS Neurosciences Inc
03/01/202413:00GlobeNewswire Inc.ProMIS Neurosciences, Inc. Announces Leadership TransitionNASDAQ:PMNProMIS Neurosciences Inc
20/12/202313:00GlobeNewswire Inc.ProMIS Neurosciences Announces Publication on Novel Target for ALSNASDAQ:PMNProMIS Neurosciences Inc
20/11/202313:00GlobeNewswire Inc.ProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
14/11/202322:30GlobeNewswire Inc.ProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
08/09/202313:00GlobeNewswire Inc.ProMIS Neurosciences Closes $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
06/09/202318:18GlobeNewswire Inc.ProMIS Neurosciences to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PMNProMIS Neurosciences Inc
21/08/202322:12GlobeNewswire Inc.ProMIS Neurosciences Announces $20.4 Million Private Placement FinancingNASDAQ:PMNProMIS Neurosciences Inc
14/08/202323:33GlobeNewswire Inc.ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
17/07/202313:00GlobeNewswire Inc.ProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s PipelineNASDAQ:PMNProMIS Neurosciences Inc
14/07/202313:45GlobeNewswire Inc.ProMIS Announces Completion of ContinuanceNASDAQ:PMNProMIS Neurosciences Inc
10/07/202313:55GlobeNewswire Inc.ProMIS Neurosciences to Consolidate Trading on the Nasdaq ExchangeNASDAQ:PMNProMIS Neurosciences Inc
30/06/202314:00GlobeNewswire Inc.ProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions ApprovedNASDAQ:PMNProMIS Neurosciences Inc
29/06/202314:00GlobeNewswire Inc.CORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern TimeNASDAQ:PMNProMIS Neurosciences Inc
15/05/202323:00GlobeNewswire Inc.ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:PMNProMIS Neurosciences Inc
08/05/202315:00GlobeNewswire Inc.ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
25/04/202323:00GlobeNewswire Inc.Data Presented at American Academy of Neurology Annual Meeting on Novel Vaccine Design for Alzheimer’s DiseaseNASDAQ:PMNProMIS Neurosciences Inc
24/04/202313:30GlobeNewswire Inc.ProMIS Neurosciences Presents Preclinical Data Highlighting Targeting of Toxic Misfolded Proteins in Alzheimer’s Disease and ALS at American Academy of Neurology Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
10/04/202313:30GlobeNewswire Inc.ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310NASDAQ:PMNProMIS Neurosciences Inc
29/03/202314:30GlobeNewswire Inc.Lead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023NASDAQ:PMNProMIS Neurosciences Inc
13/03/202314:00GlobeNewswire Inc.ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual MeetingNASDAQ:PMNProMIS Neurosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PMN

La tua Cronologia

OKEX
LAUSDT
BIT
UB6DEQ
Unicredit Bank
BIT
LUVE
LU-VE S.p.A
USOTC
AGLAF
T2 Metals (QB)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network